Navigation Links
Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit
Date:3/16/2017

SAN FRANCISCO, March 16, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Richard Chin, Chief Executive Officer, will be presenting at the 2017 Jefferies Animal Health Summit in New York, NY on Thursday, March 30, 2017 at 10:45 AM EDT. 

This conference will not be webcast. Investors and other interested parties may access the corporate presentation following this meeting at http://kindredbio.com/jefferies2017.

About Kindred Biosciences 

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.

Contact

Russell Radefeld
KindredBio
russell.radefeld@kindredbio.com 
(650) 701-7904

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-2017-jefferies-animal-health-summit-300424922.html


'/>"/>
SOURCE Kindred Biosciences, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
2. Kindred Biosciences to Announce Fourth Quarter and Year-End 2015 Financial Results
3. Kindred Biosciences to Provide Corporate Update
4. Kindred Biosciences Announces Second Quarter 2015 Financial Results
5. Kindred Biosciences Announces First Quarter 2015 Financial Results
6. Kindred Biosciences to Present at 2015 Jefferies Animal Health Summit
7. KindredBio to Announce Fourth Quarter and Year-End 2014 Financial Results
8. Avelas Biosciences Appoints Alexey Vinogradov, Ph.D., to Board of Directors
9. DuPont Industrial Biosciences Leader Presents Major Advances in Biomaterials at 2017 Advanced Bioeconomy Leadership Conference
10. Luxcel Biosciences and HD Biosciences Enter Collaboration Agreement for Mitochondria Toxicity & Metabolism Assays for Preclinical Drug Safety Evaluation
11. ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2020)... ... 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today that ... during the American Association for Cancer Research Virtual meeting. One poster describes the ... single agent activity in KEAP1 mutant tumor models of NSCLC. , ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... Phase I of a Small Business Innovation Research (SBIR) program funded by the ... Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer ...
(Date:6/2/2020)... ... June 01, 2020 , ... As ... encourage positive change in the world, enterprise security solutions provider bitsIO donated time ... people working from home during self-quarantines and shelter-in-place orders, companies are increasingly concerned ...
(Date:5/28/2020)... ... May 28, 2020 , ... The Security Industry Association (SIA) and ... winners of the Women in Biometrics Awards – a globally recognized program ... Update and the SIA Women in Security Forum . The honorees will ...
Breaking Biology Technology:
(Date:6/11/2020)... ... June 08, 2020 , ... Cryo-Cell International’s announcement comes on ... workers in the medical field. The face masks will be distributed nationwide to ... every day to provide healthcare to pregnant women. The delivery of masks is ...
(Date:6/5/2020)... ... 2020 , ... Greffex, a pioneering vaccine and gene therapy company based in ... the need for a global perspective to make an impact in a post pandemic ... serve as an independent, director of the company. , “The Greffex board is excited ...
(Date:5/28/2020)... ... 2020 , ... Today bioinformatics leader hc1® announced ... lab testing insights and hc1’s exclusive Local Risk Index in a unified CV19 ... employees returning to the workplace. , “Some of the best ways to keep ...
Breaking Biology News(10 mins):